Product Overview

Type:                                     COVID-19 Vaccine (Ad5-nCoV-S [Recombinant]) 

INN:                                       N/A

Commercial name:              Convidecia

EUL holder:                          CanSino Biologics Inc.

Country:                                People’s Republic of China

Responsible NRA:                National Medical Products Administration (NMPA)  

Country:                                People’s Republic of China

WHO EUL recommendation

Effective date:           19 May 2022

Recommendation for an Emergency Use Listing (EUL) of Convidecia COVID-19 Vaccine (Ad5/nCoV-5[recombinant]) submitted by CanSino Biologics Inc. (Published: 10 October 2022)

Product description

Pharmaceutical Form:            Sterile solution for injection

Presentation:                            2 mL / Vial

Number of doses:                     1 and 3 doses of 0.5 mL

Route of administration:         Intramuscular

Age indication:                         Individuals 18 to 59 years of age

Shelf – life:                                12 months

Storage temperature:               2°C to 8°C

Vaccine Vial monitor (VVM):  None

Preservative:                              None

Diluent:                                         None

Special storage conditions:     Not applicable

Handling of opened multi-dose vials: 

WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.

Packaging description